Search for: "By Andrew Pollack"
Results 41 - 60
of 86
Sorted by Relevance
|
Sort by Date
6 Apr 2018, 6:29 am
Pollack passed away in 2016 at the age of 98. [read post]
26 Oct 2015, 2:30 pm
Panel 1: Ethics and Healthcare Economics Moderator: Mark Siegler The True Cost of Hepatitis C Therapy (Andrew Aronsohn, The University of Chicago) Ethics of Sustainability (Stacy Lindau, The University of Chicago) Are There Ethical Standards For Health Insurance Companies? [read post]
17 Feb 2014, 1:07 am
--See also the article in the New York Times by Andrew Pollack Disgraced Scientist Granted U.S. [read post]
2 Jun 2009, 8:03 am
As reported by Andrew Pollack in the New York Times, the new study was presented at the annual meeting of the American Society of Clinical Oncology. [read post]
23 Sep 2009, 5:30 am
"According to Andrew Pollack's story for the New York Times, this decision could open the door for a ban on the beets that are planted on roughly 1.1 million acres of American farms. [read post]
31 May 2012, 3:35 pm
The Edwards case, Pollack said, was a difficult prosecution that featured solid lawyering on both sides of the courtroom. [read post]
29 Jun 2007, 1:13 am
Dean, Center for Appellate Litigation, New York (Gayle Pollack of counsel), for appellant. [read post]
6 Dec 2013, 6:29 pm
Patent Reform Progresses As House Passes Goodlatte Innovation Act – Andrew Baluch and Courtenay Brinckerhoff of Foley & Lardner on the firm’s blog, PharmaPatents For more of the best, check out LXBN, a complete review of the top insight and commentary across the LexBlog Network. [read post]
31 Mar 2010, 7:04 am
While the immediate impact will likely be muted until an appellate court weighs in on the issue, NYT reporter Andrew Pollack writes that “the invalidation of genetic patents could hit diagnostics companies, agricultural biotechnology companies and perhaps even traditional drug makers. [read post]
1 Jul 2010, 9:55 am
"Cancer Patients Challenge the Patenting of a Gene," by John Schwartz, The NY Times, published 05/12/09 "Judge Invalidates Human Gene Patent," by John Schwartz and Andrew Pollack, The New York Times, published 03/29/10 "Is It Fair to Patent Genes? [read post]
30 Mar 2010, 6:01 am
That said, the NYT’s John Schwartz and Andrew Pollack note that the ruling, if upheld, “could throw into doubt the patents covering thousands of human genes and reshape the law of intellectual property. [read post]
8 Sep 2007, 9:01 pm
Al Qaeda in Iraq, which didn't even exist on 9/11, may represent as little as 2 to 5 percent of the Sunni insurgency, according to a new investigation in The Washington Monthly by Andrew Tilghman, a former Iraq correspondent for Stars and Stripes. . . . [read post]
21 Dec 2016, 11:14 am
" That's the question that was raised nationally this week by the New York Times in connection with federally funded research dealing with life-saving treatments.The same question can be raised concerning the roughly $6 billion, including interest, that California is spending -- unsuccessfully so far -- to generate a stem cell therapy that can be widely used.In the case of the Times, the article by Matt Richtel and Andrew Pollack dealt with cancer immunotherapies and the… [read post]
10 Feb 2018, 1:14 pm
Isaac of Pollack, Pollack, Isaac & Decicco (appellate counsel for plaintiff) and Barbara D. [read post]
14 Nov 2011, 6:56 pm
Andrew Pollack of the New York Times reported, "The move is expected to be widely seen as a setback for the field, because of Geron’s central role. [read post]
15 Jan 2010, 11:18 am
Kennedy, Jr to Linda Fairstein to Eliot Spitzer to Andrew Cuomo. [read post]
14 Oct 2012, 8:50 am
As Denise Grady, Andrew Pollack and Sabrina Tavernise explained in The Times, these pharmacies fall into a legal no man’s land between the Food and Drug Administration and 50 state pharmacy boards, most of which have little expertise and limited resources to ensure the safety of these products. [read post]
26 Apr 2012, 5:28 am
Notes Pollack: “This isn’t win-win, this is win-win-win-win. [read post]
26 Apr 2012, 5:17 am
Notes Pollack: “This isn’t win-win, this is win-win-win-win. [read post]
6 Nov 2015, 11:57 am
The director of the SEC’s Division of Enforcement, Andrew Ceresney, was joined by several former enforcement directors for a spirited discussion about recent developments concerning SEC enforcement issues. [read post]
